Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
CYP4V2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Invitae Corneal Dystrophies Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 65 | 33 |
|
Invitae Congenital Stationary Night Blindness Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 36 | 22 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
PreventionGenetics, part of Exact Sciences United States | 40 | 27 |
|
Bietti Crystalline Corneoretinal Dystrophy via the CYP4V2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Congenital stationary night blindness panel. 17-gene NGS panel. Genologica Medica Spain | 25 | 17 |
|
Corneal dystrophy panel. NGS panel of 27 genes. Genologica Medica Spain | 44 | 27 |
|
Rod and cone dystrophy panel. 42-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Genologica Medica Spain | 164 | 108 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Mottled Retinal Disorders Panel. 12-gene NGS panel. Genologica Medica Spain | 25 | 12 |
|
Congenital Stationary Night Blindness NGS Panel Fulgent Genetics United States | 27 | 17 |
|
Fulgent Genetics United States | 47 | 24 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.